Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03009994
Other study ID # EUR
Secondary ID
Status Recruiting
Phase Phase 2
First received January 3, 2017
Last updated January 3, 2017
Start date September 2016
Est. completion date September 2017

Study information

Verified date January 2017
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority Egypt: Assiut Medical School Ethical Review Board
Study type Interventional

Clinical Trial Summary

Cesarean section is one of the most frequently performed major operations worldwide. It accounts for between 1% and 70% of deliveries depending on the facilities or country assessed. In Egypt, the cesarean section rate is 22%, with higher rates seen in private hospitals. In 2015 ,incidence of cesarean section rate in Woman Health Hospital in Assiut university is 51.3% of all deliveries.

Different Operational techniques For cesarean section have been defined aimed at reducing surgical time, making the surgery easier and more efficient, lowering costs,decreasing the risk of adverse effects and postoperative morbidity, as well as length of hospital stay.

Also, Intraoperative blood loss is one of important complications during cesarean section. A systematic review included twenty one studies, in 2011, revealed that increase incidence of intraoperative blood loss and blood transfusion with increase number of cesarean deliveries.also anemia in the pregnancy increase maternal morbidities included intraoperative blood loss. In Egypt, prevalence of Iron deficiency anemia among pregnant women about 51% of pregnant women.

After baby born by cesarean section and the placenta has been extracted, uterine incision is sutured either by temporary removal of the uterus from the abdominal cavity (exteriorization of the uterus) to facilitate uterine incision repair or it is repaired within the abdominal cavity (in situ repair). There had been few randomized controlled trials comparing intraoperative and postoperative morbidity following exteriorization of the uterus with non-exteriorization. The conclusions drawn from these trials have been conflicting.


Recruitment information / eligibility

Status Recruiting
Enrollment 1024
Est. completion date September 2017
Est. primary completion date August 2017
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- Pregnant women in 28 weeks

- Women who will undergo repeated lower segment cesarean section

Exclusion Criteria:

- First cesarean section

- Placenta previa.

- Rupture uterus.

- Classical caesarean section.(upper segment cesarean section)

- Sever Preeclampsia.

- Chorioamnionitis.

- prolonged or obstructed labour.

- Fibroid.

- Polyhydramnios.

- Multiple pregnancy.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
Repair of uterine incision

Exteriorization of the uterus

Non exteriorization of the uterus


Locations

Country Name City State
Egypt Assiut university Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intraoperative blood loss (mL) 20 minutes Yes
Primary Postoperative Hemoglobin (gm/L) 20 minutes Yes
Secondary Duration of operation (minutes) 20 minutes Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03366259 - Prostaglandins Before Caserean Section Phase 2/Phase 3
Completed NCT05664659 - Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section Phase 4
Completed NCT03793153 - A Novel Technique Of Uterine Cooling During Repeated Cesarean Section For Reducing Blood Loss N/A